V
Vincent Calvez
Researcher at Claude Bernard University Lyon 1
Publications - 313
Citations - 10264
Vincent Calvez is an academic researcher from Claude Bernard University Lyon 1. The author has contributed to research in topics: Viral load & Medicine. The author has an hindex of 55, co-authored 273 publications receiving 9407 citations. Previous affiliations of Vincent Calvez include École normale supérieure de Lyon & École Normale Supérieure.
Papers
More filters
Journal ArticleDOI
Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma.
Nicolas Dupin,Marc Grandadam,Vincent Calvez,Jean-Thierry Aubin,Jean-Marie Huraux,Henri Agut,Isabelle Gorin,S. Havard,F. Lamy,Michèle Leibowitch,Escande Jp +10 more
TL;DR: The results reinforce the hypothesis that an infectious agent closely related to gamma-herpesvirus is implicated in the pathogenesis of Mediterranean and AIDS-associated Kaposi's sarcoma.
Journal ArticleDOI
Convergence of the Mass-Transport Steepest Descent Scheme for the Subcritical Patlak-Keller-Segel Model
TL;DR: The convergence of the suitably interpolated in time implicit Euler scheme, defined in terms of the Euclidean Wasserstein distance, associated with the modified Patlak-Keller-Segel equation for subcritical masses is proved.
Journal ArticleDOI
Volume effects in the Keller-Segel model : energy estimates preventing blow-up
Vincent Calvez,José A. Carrillo +1 more
TL;DR: In this article, the authors obtained a priori estimates for the classical chemotaxis model of Patlak, Keller and Segel when a nonlinear diffusion or a non-linear chemosensitivity is considered accounting for the finite size of the cells.
Journal Article
Update of the drug resistance mutations in HIV-1: March 2013.
Victoria A. Johnson,Vincent Calvez,Huldrych F. Günthard,Roger Paredes,Deenan Pillay,Robert W. Shafer,Annemarie M. J. Wensing,Douglas D. Richman +7 more
TL;DR: 2 integrase strand transfer inhibitors (InSTIs), elvitegra-vir and dolutegravir, have become available and were added to the treatment of HIV-1 treat-ment-naive patients.
Journal ArticleDOI
Interactions between Atazanavir-Ritonavir and Tenofovir in Heavily Pretreated Human Immunodeficiency Virus-Infected Patients
Anne-Marie Taburet,Christophe Piketty,Corine Chazallon,Isabelle Vincent,Laurence Gérard,Vincent Calvez,François Clavel,Jean-Pierre Aboulker,Pierre-Marie Girard +8 more
TL;DR: Data from this pharmacokinetic study are consistent with the existence of a significant interaction between atazanavir and tenofovir DF in human immunodeficiency virus (HIV)-infected patients.